Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation

Overview of attention for article published in Cochrane database of systematic reviews, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

policy: 1 policy source
twitter: 21 X users

facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 264 Mendeley

Summary Policy documents X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Société des sciences vasculaires du Québec, 03 Jun 2018

Dans le décours de l’engouement récent pour le petit nouveau de la famille des AOD, l’edoxaban, voici une rétrospective des étude…

DMG Paris Descartes, 11 Apr 2018

#LectureDeLaSemaine Anti-vitamine K ou anti-Xa (AOD) dans la prévention des embolies chez les patients avec fibrillation…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.